Prostate cancer hormone therapy may affect mind
Key points
- Men with more advanced prostate cancer often undergo treatment to reduce levels of testosterone, which drives tumor growth.
- When such therapy "is used less than one year, the effects are mostly reversible," Dr.
- However, mental deficits "become persistent with long-term treatment, over two years."
- Salminen and colleagues measured the cognitive performance of 23 men with prostate cancer on 31 tests, before they started androgen deprivation therapy and at 6 and 12 months after.
Men with more advanced prostate cancer often undergo treatment to reduce levels of testosterone, which drives tumor growth. Now, a new study shows that this so-called androgen deprivation therapy can affect mental performance.
When such therapy "is used less than one year, the effects are mostly reversible," Dr. Eeva K. Salminen from University of Turku, Finland, told AMN Health. "They disappear when the treatment is stopped."
However, mental deficits "become persistent with long-term treatment, over two years."
Salminen and colleagues measured the cognitive performance of 23 men with prostate cancer on 31 tests, before they started androgen deprivation therapy and at 6 and 12 months after. The team reports their findings in the medical journal Cancer
Visual memory and recognition speed of numbers were significantly impaired at 6 months, they found, whereas verbal fluency was improved at 12 months.
"When androgen deprivation is continued for less than 12 months, detrimental cognitive performance effects should be reversible and minor," the investigators point out. However, the effects could be different in men with any underlying psychiatric or neurologic illnesses.
A man being treated for prostate cancer "should discuss this with his doctor and his spouse," Salminen advised. "Both need to understand that temporary worsening of cognitive functioning is not related to cancer, but to the treatment."
SOURCE: Cancer, April 1, 2005.
Written and revised by
Gerald Hurowitz, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
NewsStudy: Hormone therapy increases breast cancer risk, mortality
In the nearly 11 years since researchers first rang alarm bells that women on hormone replacement therapy faced an increased risk of breast cancer, some have suggested that taking estrogen and progestin to treat…
2 April 2013
NewsNovel radiation therapy method shortens prostate cancer treatment time
According to a study in the January issue of the Journal of the American College of Radiology, the use of volume-modulated arc therapy (VMAT) to deliver intensity-modulated radiation therapy (IMRT) to prostate cancer…
3 February 2013
NewsHormone pill slows prostate cancer's growth
A hormone-blocking pill approved last year for some men with advanced prostate cancer now also seems to help a wider group of men who were given it sooner in the course of treating their disease. In a study of nearly…
4 June 2012
